Literature DB >> 10908257

Does angina vary with the menstrual cycle in women with premenopausal coronary artery disease?

G W Lloyd1, N R Patel, E McGing, A F Cooper, D Brennand-Roper, G Jackson.   

Abstract

OBJECTIVE: To determine whether angina in women with established coronary heart disease varies with changes in hormone concentrations during the menstrual cycle.
DESIGN: Subjects were prospectively studied once a week for four weeks.
SETTING: Cardiology outpatient department of tertiary referral centre.
SUBJECTS: Nine premenopausal women, mean (SEM) age 38.89 (2.18) years, with established coronary heart disease, symptomatic angina, and a positive exercise test. MAIN OUTCOME MEASURE: Myocardial ischaemia as determined by time to 1 mm ST depression during symptom limited exercise testing. Position in the menstrual cycle was established from hormone concentrations.
RESULTS: The early follicular phase, when oestradiol and progesterone concentrations were both low, was associated with the worst exercise performance in terms of time to onset of myocardial ischaemia, at 290 (79) seconds; the best performance (418 (71) seconds) was when oestrogen concentrations were highest in the mid-cycle (p < 0.05). Similar trends were observed in other measured variables. Progesterone concentrations did not influence exercise performance.
CONCLUSIONS: During the menstrual cycle myocardial ischaemia was more easily induced when oestrogen concentrations were low. This may be important for timing the assessment and evaluating treatment in women with coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10908257      PMCID: PMC1760914          DOI: 10.1136/heart.84.2.189

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  23 in total

1.  Oestrogen improves exercise-induced myocardial ischaemia in women.

Authors:  C M Webb; G M Rosano; P Collins
Journal:  Lancet       Date:  1998-05-23       Impact factor: 79.321

2.  Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence.

Authors:  M J Stampfer; G A Colditz
Journal:  Prev Med       Date:  1991-01       Impact factor: 4.018

3.  Relation of results of exercise stress tests in young women to phases of the menstrual cycle.

Authors:  P I Clark; S P Glasser; G H Lyman; J Krug-Fite; A Root
Journal:  Am J Cardiol       Date:  1988-01-01       Impact factor: 2.778

4.  Blood pressure and the menstrual cycle.

Authors:  G Greenberg; J D Imeson; S G Thompson; T W Meade
Journal:  Br J Obstet Gynaecol       Date:  1985-10

5.  Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease.

Authors:  G M Rosano; P M Sarrel; P A Poole-Wilson; P Collins
Journal:  Lancet       Date:  1993-07-17       Impact factor: 79.321

6.  17 beta-Estradiol attenuates voltage-dependent Ca2+ currents in A7r5 vascular smooth muscle cell line.

Authors:  F Zhang; J L Ram; P R Standley; J R Sowers
Journal:  Am J Physiol       Date:  1994-04

7.  Migraine and menstruation: a pilot study.

Authors:  E A MacGregor; H Chia; R C Vohrah; M Wilkinson
Journal:  Cephalalgia       Date:  1990-12       Impact factor: 6.292

8.  Acute effect of 17 beta-estradiol on rabbit coronary artery contractile responses to endothelin-1.

Authors:  C Jiang; P M Sarrel; P A Poole-Wilson; P Collins
Journal:  Am J Physiol       Date:  1992-07

9.  Nitric oxide accounts for dose-dependent estrogen-mediated coronary relaxation after acute estrogen withdrawal.

Authors:  P Collins; J Shay; C Jiang; J Moss
Journal:  Circulation       Date:  1994-10       Impact factor: 29.690

10.  Menopause and the risk of coronary heart disease in women.

Authors:  G A Colditz; W C Willett; M J Stampfer; B Rosner; F E Speizer; C H Hennekens
Journal:  N Engl J Med       Date:  1987-04-30       Impact factor: 91.245

View more
  8 in total

Review 1.  Cardiovascular disease in women: sex differences in presentation, risk factors, and evaluation.

Authors:  Donna M Polk; Tasneem Z Naqvi
Journal:  Curr Cardiol Rep       Date:  2005-05       Impact factor: 2.931

2.  Estradiol improves right ventricular function in rats with severe angioproliferative pulmonary hypertension: effects of endogenous and exogenous sex hormones.

Authors:  Andrea L Frump; Kara N Goss; Alexandra Vayl; Marjorie Albrecht; Amanda Fisher; Roziya Tursunova; John Fierst; Jordan Whitson; Anthony R Cucci; M Beth Brown; Tim Lahm
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-02-20       Impact factor: 5.464

3.  Stage of the estrous cycle does not influence myocardial ischemia-reperfusion injury in rats (Rattus norvegicus).

Authors:  Chad R Frasier; David A Brown; Ruben C Sloan; Brian Hayes; Luke M Stewart; Hetal D Patel; Robert M Lust; Matthew D Rosenbaum
Journal:  Comp Med       Date:  2013-10       Impact factor: 0.982

4.  Estrous cycle-dependent neurovascular dysfunction induced by angiotensin II in the mouse neocortex.

Authors:  Carmen Capone; Josef Anrather; Teresa A Milner; Costantino Iadecola
Journal:  Hypertension       Date:  2009-06-08       Impact factor: 10.190

5.  17β-Estradiol mediates superior adaptation of right ventricular function to acute strenuous exercise in female rats with severe pulmonary hypertension.

Authors:  Tim Lahm; Andrea L Frump; Marjorie E Albrecht; Amanda J Fisher; Todd G Cook; Thomas J Jones; Bakhtiyor Yakubov; Jordan Whitson; Robyn K Fuchs; Aiping Liu; Naomi C Chesler; M Beth Brown
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-06-10       Impact factor: 5.464

6.  Renin angiotensin system and gender differences in dopaminergic degeneration.

Authors:  Ana I Rodriguez-Perez; Rita Valenzuela; Belen Joglar; Pablo Garrido-Gil; Maria J Guerra; Jose L Labandeira-Garcia
Journal:  Mol Neurodegener       Date:  2011-08-16       Impact factor: 14.195

7.  Menstruation angina: a case report.

Authors:  Wai Kah Choo
Journal:  J Med Case Rep       Date:  2009-03-27

8.  Influence of ischemia-reperfusion injury on endothelial function in men and women with similar serum estradiol concentrations.

Authors:  Sophie Lalande; Holden W Hemingway; Caitlin P Jarrard; Amy M Moore; Albert H Olivencia-Yurvati; Rauchelle E Richey; Steven A Romero
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-07-14       Impact factor: 3.210

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.